Bruker Corporation to Acquire ELITech Group from PAI Partners
December 27, 2023
PAI Partners has entered into an agreement with Bruker Corporation to sell ELITech Group, a global manufacturer of in-vitro diagnostics (IVD) instruments and reagents. The deal is subject to regulatory and customary closing conditions and includes a put option for the sale. Under PAI’s ownership since 2017, ELITech pursued R&D investments, next-generation molecular diagnostics systems, and strategic partnerships.
- Buyers
- Bruker Corporation
- Targets
- ELITech Group
- Sellers
- PAI Partners
- Industry
- Healthcare Services
- Location
- Italy
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires Optimal Industrial Automation and Technologies
April 5, 2022
Pharmaceuticals
Bruker Corporation acquired UK-based Optimal Industrial Automation and Technologies, a provider of pharma and biopharma process analytical technology (PAT), manufacturing automation and QA software (including the synTQ platform). The acquisition strengthens Bruker's biopharma manufacturing automation and PAT software capabilities to complement its instrumentation portfolio and accelerate integrated solutions for pharmaceutical and biotech customers.
-
Bruker Corporation Majority Investment in RECIPE Chemicals + Instruments GmbH
April 16, 2025
Medical Devices
Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, a Munich-based provider of mass spectrometry‑based in vitro diagnostic assay kits for therapeutic drug monitoring. The deal (financial terms undisclosed) brings RECIPE's ClinMASS kits into Bruker's portfolio and creates a strategic collaboration to introduce high‑throughput, chromatography‑free ClinDART workflows on Bruker's EVOQ‑DART TQ⁺ platform.
-
Adelis Equity Partners Acquires Majority Stake in Bruhn NewTech
June 28, 2024
Software
Adelis Equity Partners (via Adelis Equity Partners Fund III AB) has acquired a majority stake in Danish CBRN knowledge-management software provider Bruhn NewTech, with the deal closing on June 28. The investment is the first step in Adelis’ plan to build a European defense-focused technology group and will support Bruhn NewTech’s global growth and product development.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
Bruker Corporation Acquires Spectral Instruments Imaging
February 6, 2024
Medical Devices
Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.
-
Calibre Scientific Acquires Invitech Ltd.
October 14, 2024
Medical Devices
Calibre Scientific has acquired Invitech Ltd., a UK-based supplier of in‑vitro diagnostics and research kits serving clinical laboratories, CROs, public institutions and universities across the British Isles. The deal expands Calibre Scientific's product offering and distribution footprint in the UK and broader European market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.